The number of cases of mpox, formerly known as monkeypox, has spiked in the Big Apple since October, the New York City ...
A dose-sparing intradermal mpox vaccination regimen was safe and generated an antibody response equivalent to that induced by ...
The effectiveness of vaccines against the new variant remains unknown, although animal data shows promising results.
KINSHASA, Congo (AP) — Congo is struggling to contain its biggest mpox outbreak, and scientists say a new form of the disease ...
Lower dose of monkeypox vaccine is found to be safe with equal six-week antibody response, promising for vaccination strategies.
A one-fifth dose of Bavarian Nordic’s mpox vaccine Jynneos can elicit a similar antibody response as its standard-dose regimen, according to findings presented Saturday at the European Society of ...
A cluster of mpox cases in the Democratic Republic of the Congo sparks worries of a wider outbreak. A virulent strain of the ...
World Immunization Week: 507 vaccines in late-stage development, 88 using mRNA tech to prevent TB, malaria, flu, COVID-19, ...
Labcorp (NYSE:LH) announced Wednesday that the U.S. Food and Drug Administration (FDA) granted emergency use authorization for its Mpox PCR Test Home Collection Kit, which can be used to detect ...
Repurposing a Food and Drug Administration (FDA)-approved drug for a new use has been informally practiced for years. In fact, “off-label” medication administration is so common that the ...
A regulatory decision is expected on February 14, 2025. The Food and Drug Administration has accepted for review the Biologics License Application for GSK’s 5-in-1 meningococcal ABCWY (MenABCWY ...
With a final decision expected next February, MenABCWY combines the protective elements of GSK’s existing vaccines to target the five primary serogroups of Neisseria meningitidis. GSK announced that ...